Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)

BACKGROUND: Available evidence suggests that adjunctive treatment with immunomodulatory medications may be effective in the treatment of major depressive disorder (MDD). A pilot trial of the tetracycline minocycline as adjunctive treatment in treatment-resistant depression (TRD), produced promising...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Psychiatry
Päätekijät: Husain, Muhammad Ishrat, Cullen, Clare, Umer, Madeha, Carvalho, Andre F., Kloiber, Stefan, Meyer, Jeffrey H., Ortiz, Abigail, Knyahnytska, Yuliya, Husain, M. Omair, Giddens, Justine, Diniz, Breno S., Wang, Wei, Young, Allan H., Mulsant, Benoit H., Daskalakis, Zafiris J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2020
Aiheet:
Study Protocol
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7161279/
https://ncbi.nlm.nih.gov/pubmed/32295565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12888-020-02553-9
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia